Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome.
Frederik Hendrik VerbruggePieter MartensKoen AmelootVeerle HaemelsJoris PendersMatthias DupontW H Wilson TangWalter DroognéWilfried MullensPublished in: Acta cardiologica (2018)
Spironolactone use upfront in AHF patients at high risk for cardiorenal syndrome is safe and increases natriuresis.